Successful Treatment of an Aspergillus Brain Abscess with Caspofungin: Case Report of a Diabetic Patient Intolerant of Amphotericin B
Successful Treatment of an Aspergillus Brain Abscess with Caspofungin: Case Report of a Diabetic Patient Intolerant of Amphotericin B
复制标题
卡泊芬净成功治疗曲霉菌脑脓肿:两性霉素 B 不耐受的糖尿病患者病例报告
DOI:
10.1007/s10096-003-0991-6
复制
发表时间:
2003
影响因子:
4.5
通讯作者:
R. Rosas
中科院分区:
文献类型:
--
作者:
A. Colombo;R. Rosas
Aspergillosis may occur in a variety of clinical settings, including patients undergoing prolonged steroid therapy or cancer chemotherapy, patients who have undergone organ transplantation, or patients infected by the human immunodeficiency virus. Cerebral aspergillosis may occur in up to 20% of all cases of invasive aspergillosis; however, only in rare cases is the brain the sole site of infection [1]. Brain abscess due to Aspergillus spp. has been reported infrequently among immunologically competent patients [2]. We describe a diabetic patient with a brain abscess caused by Aspergillus spp. who was successfully treated with caspofungin, the first in a new class of antifungal agents known as the glucan synthesis inhibitors.A 66-year-old female diabetic patient who had suffered cranial trauma at the fronto-parietal region with a wooden beam 1 year previously presented to the emergency room complaining of frontal headache of 6 months’ duration and swelling of the skull. The physical examination was unremarkable except for swelling at the right temporo-parietal region, which exhibited inflammatory signs. Hematological and biochemical laboratory tests were normal except for mild hyperglycemia (180 mg/dl). A subsequent cranial computed tomography (CT) scan showed an area consistent with soft tissue infection and osteomyelitis and revealed the presence of a contiguous brain abscess at the temporo-parietal region circumscribed by cerebral edema (Fig. 1A, B). No other structural abnormalities in the underlying brain areas were detected.